Process and operations strategies to enable global access to antibody therapies
Abstract
Few monoclonal antibodies are currently approved for treating infectious diseases, but multiple products are in development against a broad range of infectious diseases, including Ebola, influenza, hepatitis B, HIV, dengue, and COVID-19. The maturity of mAb technologies now allow us to identify and advance neutralizing mAb products to the clinic at null pace, as the pipeline of mAbs targeting SARS-CoV-2 has demonstrated. Ensuring global access...
Paper Details
Title
Process and operations strategies to enable global access to antibody therapies
Published Date
Mar 16, 2021
Journal
Volume
37
Issue
3
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History